Skip to main content
Top

Diabetes Therapy

Issue 7/2021

Content (26 Articles)

Open Access Spironolactone Review

The Role of Finerenone in the Management of Diabetic Nephropathy

Stavroula Veneti, Konstantinos Tziomalos

Open Access Insulins Original Research

Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study)

Jan Brož, Denisa Janíčková Žďárská, Jana Urbanová, Pavlína Piťhová, Viera Doničová, Sabina Pálová, Barbora Pelechová, Anna Smržová, Milan Kvapil

Open Access Insulins Original Research

Prospective Independent Evaluation of the Carbohydrate Counting Accuracy of Two Smartphone Applications

Michael Joubert, Laurent Meyer, Aline Doriot, Bleuenn Dreves, Nathalie Jeandidier, Yves Reznik

Open Access Type 2 Diabetes Original Research

The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective

Heather Gelhorn, Zaneta Balantac, Shraddha Shinde, Vivian Thuyanh Thieu, Kristina S. Boye

Open Access Insulins Original Research

Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study

Shuhei Nakanishi, Masashi Shimoda, Fuminori Tatsumi, Kenji Kohara, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Takatoshi Anno, Fumiko Kawasaki, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto

Open Access Insulins Original Research

Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 Diabetes

Ashkan Dehghani Zahedani, Solmaz Shariat Torbaghan, Salar Rahili, Kirill Karlin, Darrin Scilley, Riya Thakkar, Maziyar Saberi, Noosheen Hashemi, Dalia Perelman, Nima Aghaeepour, Tracey McLaughlin, Michael P. Snyder

Open Access Hypoglycemia Original Research

A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients

Yingying Luo, Hong Wu, Xiyang Liao, Tingting Zhao, Nan Cui, Aihua Li, Xingzhi Sun, Puhong Zhang, Yahua Huang, Xia Zhang, Huiqiu Yin, Linong Ji

Open Access Metformin Original Research

Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis

Jane L. Tarry-Adkins, Imogen D. Grant, Susan E. Ozanne, Rebecca M. Reynolds, Catherine E. Aiken

Open Access Pharmacokinetics Original Research

Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation

Tine A. Bækdal, Astrid Breitschaft, Morten Donsmark, Stine J. Maarbjerg, Flemming L. Søndergaard, Jeanett Borregaard

Open Access Dulaglutid Original Research

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

Luis-Emilio García-Pérez, Kristina S. Boye, Myriam Rosilio, Heike Jung, Elke Heitmann, Kirsi Norrbacka, Marco Orsini Federici, Raffaella Gentilella, Bruno Guerci, Francesco Giorgino, Ulrich Aigner, Hélène Sapin

Open Access Dapagliflozin Original Research

Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand

Chaicharn Deerochanawong, Kriengsak Vareesangthip, Dilok Piyayotai, Dittaya Thongsuk, Nuch Pojchaijongdee, Unchalee Permsuwan

Open Access Diabetes Original Research

Pill Counting in the Determination of Factors Affecting Medication Adherence in Patients with Type 2 Diabetes: A Retrospective Observational Study

Megumi Shiomi, Momoka Kurobuchi, Yoichi Tanaka, Tesshu Takada, Katsuya Otori

Open Access Coronary Heart Disease Original Research

Electronic Medical Record Risk Modeling of Cardiovascular Outcomes Among Patients with Type 2 Diabetes

Dongzhe Hong, Daniel Fort, Lizheng Shi, Eboni G. Price-Haywood

Open Access Insulins Original Research

Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial

Steven J. Russell, Courtney Balliro, Magnus Ekelund, Firas El-Khatib, Tina Graungaard, Evelyn Greaux, Mallory Hillard, Rabab Z. Jafri, Naveen Rathor, Raj Selagamsetty, Jordan Sherwood, Edward R. Damiano

Open Access Sulfonylurea Original Research

A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

Hirotaka Watada, Yasushi Kawakita, Keiko Tanaka, Akinori Oh, Nobuhiro Nishigaki, Tadashi Nakajima, Keita Fujikawa, Manabu Akazawa

Open Access Insulin Glargine Original Research

Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study

Milena Velojic-Golubovic, Vojislav Ciric, Marija Dimitrijevic, Tijana Kovic, Milica Mitic, Biljana Olujic, Natasa Pevac, Sasa Radenkovic, Danijela Radojkovic, Selena Vukadinovic, Djordje S. Popovic

Open Access Type 2 Diabetes Original Research

Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study

Marie-Christine Turnin, Pierre Gourdy, Jacques Martini, Jean-Christophe Buisson, Marie-Christine Chauchard, Jacqueline Delaunay, Solène Schirr-Bonnans, Soumia Taoui, Marie-France Poncet, Valeria Cosma, Sandrine Lablanche, Magali Coustols-Valat, Lucie Chaillous, Charles Thivolet, Caroline Sanz, Alfred Penfornis, Benoît Lepage, Hélène Colineaux, Michaël Mounié, Nadège Costa, Laurent Molinier, Hélène Hanaire

Open Access Type 2 Diabetes Brief Report

Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019

Kristina S. Boye, Maureen J. Lage, Shraddha Shinde, Vivian Thieu, Jay Patrick Bae

Open Access Insulins Brief Report

Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

David A. Price, Qianqian Deng, Mark Kipnes, Stayce E. Beck

Open Access Dapagliflozin Study Protocol

Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial

Gian Pio Sorice, Francesca Cinti, Lucia Leccisotti, Domenico D’Amario, Margherita Lorusso, Maria Angela Guzzardi, Teresa Mezza, Camilla Cocchi, Umberto Capece, Pietro Manuel Ferraro, Filippo Crea, Alessandro Giordano, Patricia Iozzo, Andrea Giaccari

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine